Low-dose aspirin or heparin significantly improves live birth rates and reduces complications in women with recurrent pregnancy loss.

A study has revealed that approximately 20% of women facing medlinkrecurrent pregnancy/medlink loss test positive for an antibody that attacks their...

Recurrent pregnancy loss occurs in women who have lost two or more pregnancies for unknown reasons. Dr. Kenji Tanimura and his team at Kobe...

New therapy for women with recurrent pregnancy loss caused due to own antibodies,hasincreasedlive birth rates from 50% to 87% and reduced pregnancy...

− Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial − FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in Japan...

New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...

New research findings of the ENZAMET (ANZUP 1304) study, led by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP),...

Early high-efficacy treatment drastically lowers long-term disability risk in children with multiple sclerosis, offering better outcomes for their...

In the months after the U.S. Supreme Court struck down the constitutional right to an abortion, there was a spike in the number of women seeking...

Researchers found that SARS-CoV-2-specific plasma cells were largely excluded from the long-lived plasma cell compartment in the bone marrow after...